Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
06/2010
06/30/2010CN101757228A Traditional Chinese medicine preparation for treating diabetes
06/30/2010CN101757189A 一种补钙制剂 One kind of calcium preparations
06/30/2010CN101757176A Extraction and activity determination method of novel alpha-glucosidase inhibitor
06/30/2010CN101757166A Ejiao general paste
06/30/2010CN101757159A Foot bathing liquid for adjuvant therapy of diabetes
06/30/2010CN101757152A Application of traditional Chinese medicine composition in preparation of medicines for treating ischemic diabetic foot
06/30/2010CN101757114A Hypoglycemic product and preparation method thereof
06/30/2010CN101757100A Basil seed chewable tablets
06/30/2010CN101757079A Chewable tablet containing honeysuckle and preparation method thereof
06/30/2010CN101757073A Medicinal composition containing atractylodes rhizome extractive
06/30/2010CN101757059A Method for extracting alpha-glucosidase activity inhibitor from plants
06/30/2010CN101757057A Whiteflower leadword root chewable tablet
06/30/2010CN101757056A Extract of yangtao actinidia root and preparation method and applications thereof
06/30/2010CN101757048A Ginkgo leaf-containing chewable tablet and preparation method thereof
06/30/2010CN101757034A Preparation process for water soluble biological calcium magnesium oral liquor
06/30/2010CN101757021A Compound infusion preparation applicable to canine fluid infusion and preparation method thereof
06/30/2010CN101757019A Medical composition for losing weight or treating metabolic syndromes
06/30/2010CN101757012A Application of hyperin in preparation of medicament for treating diabetes
06/30/2010CN101757007A Melbine/acarbose hypoglycemic oral preparation composition and preparation thereof
06/30/2010CN101757002A Metformin-glibenclamide capsule and preparation method thereof
06/30/2010CN101757000A Medicament for supplying DE calcium and preparation method thereof
06/30/2010CN101756993A Medical composition for losing weight or treating metabolic syndromes
06/30/2010CN101756990A Medical composition for losing weight or treating hyperlipidemia
06/30/2010CN101756980A Melbine/migltol hypoglycemic oral preparation composition and preparation thereof
06/30/2010CN101756971A Oral solid drug composition of metformin hydrochloride repaglinide
06/30/2010CN101756962A Compound nateglinide valsatan medicinal composition
06/30/2010CN101756959A Nutritional composition for improving anti-stress ability of aquacultural animals, preparation method and applications thereof
06/30/2010CN101756955A Chinonin complex, preparation method and application thereof
06/30/2010CN101756937A Combined capsule with replaglinide solid preparation and dimethyldiguanide solid preparation
06/30/2010CN101756925A Glipizide long-acting slow-release preparation and preparation method thereof
06/30/2010CN101756923A Lovastatin and nicotinic acid double-layer sustained release tablets and preparation process
06/30/2010CN101756892A Xylitol injection and preparation method thereof
06/30/2010CN101756329A Preparation method of drink for softening cardio-cerebal blood vessels
06/30/2010CN101756242A Application of flax leaf plant extract in preparing health foods
06/30/2010CN101756179A Application of rheum officinale and oolong tea extract in preparing health-care food
06/30/2010CN101756172A Method for preparing soluble plantain seed dietary fiber and application thereof
06/30/2010CN101755953A Green tea extract with blood sugar reducing effect and preparation method thereof
06/30/2010CN101332188B Method for preparing powder injection using attritioning technique and prepared products
06/30/2010CN101084937B Ginkgo leaves freezing-dried powder injection and preparation method thereof
06/29/2010US7745694 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
06/29/2010US7745689 Nephropathy-associated gene
06/29/2010US7745604 genetic enhancers comprising the nucleotide sequences that elevates transcription of a heterologous coding sequence in a host cell
06/29/2010US7745488 Therapy for neutropenia as result of radiation therapy; administering colony stimulating factor
06/29/2010US7745481 Methods and compositions for the treatment and prevention of tumors, tumor-related disorders and cachexia
06/29/2010US7745450 5-[1-(hydroxymethyl)propyl]amino-7-benzylamino-3-isopropyl(methyl, ethyl)pyrazolo[4,3-d]pyrimidine for inhibiting cell proliferation, cancer, or psoriasis, rheumatoid arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, graft rejection, and neurodegerative diseases
06/29/2010US7745447 6-(4-Chlorophenyl)-3-(5-hydroxypyridin-2-yl)thieno[3,2-d]pyrimidin-4(3H)-one, for example; for treating a patient suffering from an MCHR-1 modulated disease or disorder such as obesity, diabetes, depression or anxiety
06/29/2010US7745406 Kit which determines concentration of phosphate metabolizing protein and utilizes profile as indicator of hypo/hyperphosphatemic disorders
06/29/2010CA2455987C Tetrahydroindolone and purine derivatives linked to arylpiperazines
06/29/2010CA2455628C Neuroprotective drug comprising flibanserin
06/29/2010CA2452471C Enhancement of transfection of dna into the liver
06/29/2010CA2441696C Formulation to treat or prevent parasitic infection
06/29/2010CA2426885C Complexes of phosphate derivatives
06/29/2010CA2417942C 2-(4-pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones
06/29/2010CA2401942C Pharmaceutical compositions for buccal and pulmonary application
06/29/2010CA2382885C Rhodamine derivatives for photodynamic diagnosis and treatment
06/29/2010CA2345985C Substituted 1,3-diaryl-2-pyrid-2-yl-3-(pyrid-2-ylamino)propanol derivatives,processes for their preparation, pharmaceuticals comprising these compounds and their use
06/29/2010CA2312936C Compositions and methods for weight reduction
06/24/2010WO2010071853A1 Thiazolopyridine sirtuin modulating compounds
06/24/2010WO2010071822A1 Piperidine and piperazine derivatives and methods of use thereof
06/24/2010WO2010071819A1 Bicyclic heterocyclic derivatives and methods of use thereof
06/24/2010WO2010071783A1 Thiazoles as cannabinoid receptor ligands
06/24/2010WO2010071321A2 ORAL FORMULATIONS CONTAINING METFORMIN AND α-GLYCOSIDASE INHIBITOR, AND PREPARATION METHOD THEREOF
06/24/2010WO2010071232A1 A disintegrating tablet
06/24/2010WO2010070618A2 A microencapsulation process of sertoli cells, microcapsules obtained and their use for prevention and cure of type 1 diabetes mellitus
06/24/2010WO2010070343A1 1,3,4-oxadiazole derivatives and their uses to treat diabetes
06/24/2010WO2010069281A1 Polysaccharide from the goji berry fruit for kidneys and pancreas
06/24/2010WO2010069140A1 Medicinal product of oryzanol and preparation method thereof
06/24/2010WO2010069139A1 Pharmaceutical composition and preparation method thereof
06/24/2010WO2010069138A1 Oryzanol composition and preparation method thereof
06/24/2010WO2010069124A1 Amide thiazole derivative, preparation method and uses thereof
06/24/2010WO2010049590A3 A new pharmaceutical product
06/24/2010WO2010022201A3 Folinic acid derivatives for promoting bone growth
06/24/2010WO2010010112A3 Construct and method for the internalization of cargo molecules into a cell
06/24/2010US20100162421 Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
06/24/2010US20100160427 Method of treating vascular injuries induced by an excess of plasma lipids using combinations of vasoprotective agents
06/24/2010US20100160412 Methods of modulating metabolic memory
06/24/2010US20100160409 Highly Branched Reagents For Modifying Biopharmaceuticals, Their Preparation And Use
06/24/2010US20100160397 Oxazole derivatives and their use in the treatment of diabetes and obesity
06/24/2010US20100160395 Cyclopropyl compounds
06/24/2010US20100160392 Histone deacetylase inhibitors
06/24/2010US20100160386 4-phenoxy-nicotine acid derivatives and use thereof as ppar-modulators
06/24/2010US20100160383 Pyrazole carboxamide derivatives, pharmaceutical compositions and its preparation
06/24/2010US20100160359 Modulators of Metabolism and the Treatment of Disorders Related Thereto
06/24/2010US20100160354 Novel compounds
06/24/2010US20100160349 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
06/24/2010US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160328 New compounds useful for dpp-iv enzyme inhibition
06/24/2010US20100160323 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE
06/24/2010US20100160318 3-Pyrrolo[b]Cyclohexylene-2-Dihydroindolinone Derivatives and Uses Thereof
06/24/2010US20100160310 2,4 (4,6) pyrimidine derivatives
06/24/2010US20100160306 Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists
06/24/2010US20100160302 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them
06/24/2010US20100160286 Heteroarylcarbamoylbenzene derivatives for the treatment of diabetes
06/24/2010US20100160282 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
06/24/2010US20100160255 Spiro-cyclic compound
06/24/2010US20100160245 Quercetin-Containing Compositions
06/24/2010US20100160237 Dry feedstuff for controlling excess weight and obesity of dogs
06/24/2010US20100160232 Physiologically active complex comprising protamine and/or salt thereof and an acidic macromolecular substance, and use thereof
06/24/2010US20100160226 Y-receptor agonists
1 ... 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 ... 1298